Goldman Sachs invested around ¥10 billion in Kakehashi (Tokyo), a company developing operational systems for dispensing pharmacies. This marks Goldman Sachs’ first investment in a Japanese startup in two years, following its funding of the taxi-hailing app GO.
Together with contributions from other investors, Kakehashi has secured a total of approximately ¥14 billion in its Series D funding round.
Founded in 2017, Kakehashi offers a suite of products for pharmacies, including Musubi, a cloud-based electronic medication record and guidance tool. The company’s solutions now cover over 20% of pharmacies in Japan, with more than 14,000 locations nationwide.
In response to recent amendments to Japan’s Pharmaceuticals and Medical Devices Act (PMD Act) and revisions to medical service fees, Kakehashi’s platform has become a key driver of next-generation pharmacy transformation. It has contributed to strengthening pharmacist-patient relationships, improving medication adherence, and enhancing pharmacy management.
Recently, Kakehashi was selected for the Ministry of Economy, Trade and Industry’s (METI) “Demonstration Project to Promote PHR Utilization in Medical Institutions” and has advanced both technological research and social implementation through collaborations with medical institutions and universities.
[Souce]
Company’s Official Site https://www.kakehashi.life/news-post/20250610-01